CDC いわゆる子宮頚がんワクチン男児（男性）接種推奨

米国疾病管理予防センター（CDC）の予防接種の実施に関する諮問委員会　というのが厚労省の訳らしい。

そこが、男児　11-12歳に　HPVワクチン、ルーチン接種、13-21歳までの"catch-up"ワクチンを推奨

The "Human papillomavirus (HPV) vaccination" footnote now clarifies that although HPV vaccination is not specifically recommended for HCP, HCP should receive the HPV vaccine if they are in the recommended age group. This footnote also was changed to reflect the recommendation of the quadrivalent human papillomavirus (HPV4) vaccine for males at age 11 or 12 years and catch-up vaccination for males 13 through 21 years of age. Males 22 through 26 years of age may be vaccinated with HPV4 vaccine.

Recommended Adult Immunization Schedule — United States, 2012
WeeklyFebruary 3, 2012 / 61(04);1-7
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a9.htm?s_cid=mm6104a9_w



子宮頚がんワクチンと言い続けるのだろうか？


参考：

米国：口腔内HPV感染率　男女７％；　年齢、男性、性的行為、現行喫煙がリスク要素（H24.1.27)